Search | Page 34 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (SS1)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... This pilot study investigates clinical benefit of four 28-day cycles of sertraline in low-risk MDS patients. ...

    Clinical Trial last updated 04/28/2016 - 10:17am.

  2. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... illness likely to interfere with participation in this clinical study   Donor Exclusion Criteria Identical twin Female ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  3. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Any medical condition which, in the opinion of the clinical investigator, would interfere with the evaluation of the patient. ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  4. Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... This is a Phase 2, open-label, randomized, controlled clinical study of pediatric subjects treated with pamidronate with calcium and ...

    Clinical Trial last updated 04/27/2016 - 3:48pm.

  5. Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... to assess the safety, tolerability, and preliminary clinical effects of BVD-523 given orally, twice daily for 21-day cycles, in ...

    Clinical Trial last updated 04/27/2016 - 3:39pm.

  6. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... stage the selected dose will be confirmed and evaluated for clinical activity, including response rate. Status:  ...

    Clinical Trial last updated 04/27/2016 - 2:05pm.

  7. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) infusion, in ...

    Clinical Trial last updated 04/27/2016 - 1:31pm.

  8. A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... dysplasia, and Chronic Myelomonocytic Leukemia (CMML). This clinical study includes two components: (a) a Phase 1b safety lead in and (b) a ...

    Clinical Trial last updated 04/27/2016 - 1:20pm.

  9. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  10. Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:38pm.